Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Phcog.Net JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS Volume 9 · Issue 4 2018 · pp. 167–200
    Search this issue

    Cover: Journal of Pharmacology and Pharmacotherapeutics

    Journal of Pharmacology and Pharmacotherapeutics

    Volume 9, Issue 4

    2018 · pp. 167–200 · 8 articles

    Volume
    9
    Issue
    4
    Published
    2018
    Pages
    167–200
    Articles
    8
    Sections
    4
    ISSN
    ISSN: Print - 0976-500X, Online - 0976-5018
    Journal
    J Pharmacol. Pharmacother.

    In this issue

    Research Paper

    1. Article

      Impact of Concomitant Use of Beta blocker, Statin, Aspirin, and Metformin on Central Hemodynamics and Arterial Stiffness in Hypertension

      Jayesh Dalpatbhai Solanki, Hemant B. Mehta, Sunil J. Panjwani, Hirava B. Munshi, Chinmay J. Shah

      pp. 167–173 · DOI: 10.4103/jpp.JPP_62_18 · Published 2018

      Objective: To assess the impact of concomitant use of aspirin, BB (metoprolol), statin (atorvastatin), and metformin on central haemodynamics and arterial stiffness parameters in treated hypertensive patients. Materials

    2. Article

      A Randomized Open‑label Study to Evaluate the Effects of Escitalopram and Mirtazapine on Psychomotor Functions and Memory in Patients with Depression

      Anal Modi, Mira Desai, Samidh Shah, Minaxi Parikh

      pp. 174–179 · DOI: 10.4103/jpp.JPP_66_18 · Published 2018

      Objective: To compare the effects of escitalopram and mirtazapine on psychomotor functions and memory and also to correlate the antidepressant efficacy of these drugs with psychomotor functions. Materials and Methods: Th

    3. Article

      A Novel Potential Role of Vitamin K2‑7 in Relieving Peripheral Neuropathy

      Dilip S. Mehta, Yogesh A. Dound, Shashank S. Jadhav, Abhay A. Bhave, Milind Devale, Ashok D. B. Vaidya

      pp. 180–185 · DOI: 10.4103/jpp.JPP_72_18 · Published 2018

      Objective: To assess the efficacy, tolerability and safety of vitamin K2‑7 in patients with peripheral neuropathy (PN). Materials and Methods: This study was conducted in 100 patients with PN suffering from VBD or T2DM.

    4. Article

      In vitro Effects of a Novel Silver‑based Complex on Influenza Virus

      Vladimir Silnikov, Evgenii Plotnikov

      pp. 186–190 · DOI: 10.4103/jpp.JPP_50_18 · Published 2018

      Objective: To study the mechanism of antiviral activity of a new silver‑based compound of general formula C6H19Ag2N4 LiO6S2 on influenza virus. Materials and Methods: Antiviral properties were investigated on test cultur

    Case Report

    1. Article

      Complete Response to Afatinib in Lung Adenocarcinoma of Epidermal Growth Factor Receptor Exon-19 Deletion Mutation and Disease Recurrence on Drug Discontinuation

      Rashmi Kumari, Emmanuel James, K. Pavithran

      pp. 191–4 · DOI: 10.4103/jpp.JPP_111_18 · Published 2018

      Lung adenocarcinoma, the most widespread cause of neoplasm associated mortality in both men and women worldwide, is a subtype of non-small cell lung cancer (NSCLC). We address here the case of a 62-year-old female presen

    2. Article

      Crizotinib-induced Photoallergic Dermatitis: A Case Report of an Unconventional Adverse Effect of a Novel Molecule

      Rajeshwari Dabas, Manasa Shettisara Janney, Sandeep Arora, Radhakrishnan Subramaniyan

      pp. 195–7 · DOI: 10.4103/jpp.JPP_106_18 · Published 2018

      Crizotinib is a novel tyrosine kinase inhibitor approved globally for the treatment of patients with locally advanced or metastatic non-small cell lung carcinoma (NSCLC) which is anaplastic lymphoma kinase (ALK) positive

    Correspondence

    1. Article

      Coagulopathy: A Possible Mechanism of Terlipressin-induced Peripheral Ischemic Complications – Evidence from Published Case Reports

      Phulen Sarma, Vidya Mahalmani, Shammy Chandel, Subodh Kumar, Hardeep Kaur, Ajay Prakash, Deba Prasad Dhibar, Bikash Medhi

      pp. 198–9 · DOI: 10.4103/jpp.JPP_127_18 · Published 2018

      The coagulopathy may be the result of release of Von willebrand factor (VWF) or direct platelet activation by vasopressin, which may be responsible in addition to other factors for the cutaneous necrotic lesions.

    Erratum

    1. Article

      Erratum: Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial

      1. Shinde VA, Kalikar M, Jagtap S, Dakhale GN, Bankar M, Bajait CS, et al. Efficacy, safety of oral diclofenac versus transdermal diclofenac patch in

      pp. 200–200 · DOI: 10.4103/0976-500X.251391 · Published 2018

      In the article titled “Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial”, published on pages 166-171, Issue 4, V